First-of-its-Kind Bio-Hermes Challenge Sparks Global Interest for Novel Research
Such support acknowledges the promise in what is seen as ground-breaking early blood testing studies for Alzheimer’s disease.
- Such support acknowledges the promise in what is seen as ground-breaking early blood testing studies for Alzheimer’s disease.
- The first round of applicants for the Bio-Hermes Biomarker Data Challenge have been notified with many starting their projects, working to finalize them in time for a showcase event in 2025.
- The projects from these applicants are already reflecting the ambition of the Challenge to spark novel research and generate high-impact output, utilizing the unique data from the Bio-Hermes study.
- We encourage them to ask and answer questions that have yet to be posed with unencumbered creativity--this is why we devised the Challenge.